what is missing is the obvious elephant in the room - the pharms that make the product AGREE to the price control. Which they wouldn't if they were actually taking a loss. Which makes countries that don't have price controls their cash cows. For instance, an albuterol inhaler in the US runs $70 otc cash. From Canada, less than $20. It contains 20mg of albuterol. Is albuterol really that expensive? nope. The cost is pennies or fractions on a billion unit run. Why do they charge $70 in the US? Because they can.
“——an albuterol inhaler in the US runs $70 otc cash. From Canada, less than $20.”
I thought albuterol was prescription only,not OTC.
.
.